Weight loss jabs like Wegovy and Ozempic have been shown to cut people’s risk of heart attack or stroke regardless of how ...

Using the weight loss jab Wegovy may help reduce a person’s risk of heart attack or stroke, regardless of how much weight ...

A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body’s ...

Using the weight loss jab Wegovy may help reduce a person’s risk of heart attack or stroke, regardless of how much weight ...

October 22, 2025 expert reaction to study looking at semaglutide and cardiovascular health with or without weight loss . A study published in the Lancet looks at semaglutide and c ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...

This case of a 80-year-old woman with chest pain is used to demonstrate the signs and symptoms of sundowning, along with its management.

The nasal polyps market presents opportunities with multiple pipeline drugs in various development stages, targeting novel treatment approaches. Focused efforts by key players like AstraZeneca ...

Weight-loss jabs reduce the risk of heart attack even if people do not lose any weight or were not obese to start with, ...

Coronary artery calcium (CAC) is a marker of subclinical atherosclerosis that confers increased risk of atherosclerotic ...

Low-dose aspirin may reduce risk for cancer development among older individuals with clonal hematopoiesis of indeterminate ...

The integration of artificial intelligence (AI) into drug discovery is revolutionizing pharmaceutical research by providing sophisticated tools for understanding and predicting complex biological ...